Literature DB >> 28557655

Tear Film Stability in Sjögren Syndrome Patients Treated with Hyaluronic Acid Versus Crosslinked Hyaluronic Acid-Based Eye Drops.

Carlo Cagini1, Giovanni Torroni1, Tito Fiore1, Alessio Cerquaglia1, Marco Lupidi1, Pasquale Aragona2, Barbara Iaccheri1.   

Abstract

PURPOSE: To compare the stability of the tear film after instillation of eye drops containing hyaluronic acid (HA) or crosslinked hyaluronic acid (CLHA)-based in patients with Sjögren syndrome-related dry eye (SSDE).
METHODS: Forty subjects were included in this study and were divided into 2 groups: the first group (control group) consisted of 20 healthy volunteers; the second group (study group) constituted of 20 suffering from SSDE; before and 5, 30, and 60 min after instillation of eye drops the surface regularity index (SRI) and surface asymmetry index (SAI) were registered.
RESULTS: Comparing HA and CLHA, in the control group, SAI show statistically significant difference in the time 0 and in time 5, whereas there is no a statistically significant difference after 30 and 60 min from instillation. For SRI there is no statistically significant difference at any time. In SSDE group there is no statistically significant difference in the time 0 and 5, whereas there is a statistically significant difference after 60 min for SAI, and after 30 and 60 min for SRI from instillation. Both SRI and SAI in dry eyes were significantly greater than in control eyes (P < 0.05).
CONCLUSION: Our study showed a better efficacy of CLHA compared with HA in maintaining the stability of the tear film in a patient suffering from SSDE.

Entities:  

Keywords:  Sjögren Syndrome; crosslinked hyaluronic acid; eye drops; stability; tear film

Mesh:

Substances:

Year:  2017        PMID: 28557655     DOI: 10.1089/jop.2016.0149

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  3 in total

1.  Efficacy and safety of dual-polymer hydroxypropyl guar- and hyaluronic acid-containing lubricant eyedrops for the management of dry-eye disease: a randomized double-masked clinical study.

Authors:  Marc Labetoulle; Stefanie Schmickler; David Galarreta; Daniel Böhringer; Abayomi Ogundele; Michel Guillon; Christophe Baudouin
Journal:  Clin Ophthalmol       Date:  2018-12-05

2.  Novel Artificial Tears Containing Cross-Linked Hyaluronic Acid: An In Vitro Re-Epithelialization Study.

Authors:  Arianna Fallacara; Silvia Vertuani; Giacomo Panozzo; Alessandra Pecorelli; Giuseppe Valacchi; Stefano Manfredini
Journal:  Molecules       Date:  2017-11-30       Impact factor: 4.411

Review 3.  Modern approach to the treatment of dry eye, a complex multifactorial disease: a P.I.C.A.S.S.O. board review.

Authors:  Pasquale Aragona; Giuseppe Giannaccare; Rita Mencucci; Pierangela Rubino; Emilia Cantera; Maurizio Rolando
Journal:  Br J Ophthalmol       Date:  2020-07-23       Impact factor: 4.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.